I also regret giving them my data. At work, we bought one of their first kits. We were doing genetics research and my boss got some for Christmas and gifted them to everyone in the group.
Technically, 23andme is also pretty bad, which is hard to understand given that they employ very competent people and they are well funded. Seems like a space ripe for disruption. Their biggest competitor, DecodeME, never really aimed at B2C and just used customers to harvest data, then sold to a pharma.
23andme genetic risk scores are mediocre at best. Promethease makes better predictions. For example, in my case I have a high risk MHC allele, which is both trivial to predict and well understood since the 1980s. Never popped up on their reports, yet it is the first item you see if you feed your 23andme raw data to Promethease, or if you analyze the data yourself.
Technically, 23andme is also pretty bad, which is hard to understand given that they employ very competent people and they are well funded. Seems like a space ripe for disruption. Their biggest competitor, DecodeME, never really aimed at B2C and just used customers to harvest data, then sold to a pharma.
23andme genetic risk scores are mediocre at best. Promethease makes better predictions. For example, in my case I have a high risk MHC allele, which is both trivial to predict and well understood since the 1980s. Never popped up on their reports, yet it is the first item you see if you feed your 23andme raw data to Promethease, or if you analyze the data yourself.